Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Industry News

SMT’s Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years

November 19, 2025

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Industry News

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

November 23, 2015

News Industry News

Orlando Heart Specialists Selected for American College of Cardiology SMARTCare Program

June 09, 2015

News Industry News

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

February 24, 2015

News Industry News

META-ANALYSIS DEMONSTRATES REDUCTION IN MORTALITY WITH PCI COMPARED TO MEDICAL THERAPY IN STABLE PATIENTS SELECTED ON THE BASIS OF ISCHEMIA

October 28, 2013

News Industry News

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

May 14, 2012

News Industry News

St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology

August 31, 2011

News Industry News

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

August 01, 2011

Advertisement

SMT’s Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

Orlando Heart Specialists Selected for American College of Cardiology SMARTCare Program

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

META-ANALYSIS DEMONSTRATES REDUCTION IN MORTALITY WITH PCI COMPARED TO MEDICAL THERAPY IN STABLE PATIENTS SELECTED ON THE BASIS OF ISCHEMIA

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content